Melanoma 2016 | CURE

The New Front Line in Melanoma: Immunotherapy OR Targeted Agents?

May 26, 2016

Features

In the fast-moving world of melanoma treatment, new therapeutic options for patients with metastatic disease are emerging faster than oncology researchers can establish guidelines for their optimal clinical use. That is raising questions about which should be the firstline choice in metastatic melanoma — targeted drugs or immunotherapy — and how these drugs should be sequenced.